Osteoscan

Australia/Osteoscan provides bone density scanning services including vertebral fracture assessment and bone resorption marker testing. They have participated in international drug trials for over 30 years as a diagnostic partner for pharmaceutical research. Their reports integrate lifestyle factors with clinical data to guide treatment decisions[2]. In the UK/Osteoscan UK Ltd offers commercial bone mineral density measurements using EchoS REMS technology—a radiation-free diagnostic tool providing immediate results. The company was first to offer this service commercially in Britain[7]. No direct clinical trial results are published by the company itself; rather they serve as a contract diagnostic provider supporting pharma/biotech studies.